Prevalence of hepatitis C infection in New York City, 2004

Katherine Bornschlegel, Magdalena Berger, Renu K. Garg, Amado Punsalang, Christy M. McKinney, R. Charon Gwynn, Lorna Thorpe

Research output: Contribution to journalArticle

Abstract

Hepatitis C virus (HCV) is the leading cause of chronic liver disease in the United States. Accurate hepatitis C prevalence estimates are important to guide local public health programs but are usually unavailable to local health jurisdictions. National surveys may not reflect local variation, a particular challenge for urban settings with disproportionately large numbers of residents in high-risk population groups. In 2004, the New York City Department of Health and Mental Hygiene conducted the NYC Health and Nutrition Examination Survey, a population-based household survey of non-institutionalized NYC residents ages 20 and older. Study participants were interviewed and blood specimens were tested for antibody to HCV (anti-HCV); positive participants were re-contacted to ascertain awareness of infection and to provide service referrals. Of 1,786 participants with valid anti-HCV results, 35 were positive for anti-HCV, for a weighted prevalence of 2.2% (95% confidence interval [CI] 1.5% to 3.3%). Anti-HCV prevalence was high among participants with a lifetime history of injection drug use (64.5%, 95% CI 39.2% to 83.7%) or a lifetime history of incarceration as an adult (8.4%, 95% CI 4.3% to 15.7%). There was a strong correlation with age; among participants born between 1945 and 1954, the anti-HCV prevalence was 5.8% (95% CI 3.3% to 10.0%). Of anti-HCV positive participants contacted (51%), 28% (n∈=∈5) first learned of their HCV status from this survey. Continued efforts to prevent new infections in known risk behavior groups are essential, along with expansion of HCV screening and activities to prevent disease progression in people with chronic HCV.

Original languageEnglish (US)
Pages (from-to)909-917
Number of pages9
JournalJournal of Urban Health
Volume86
Issue number6
DOIs
StatePublished - Nov 2009

Fingerprint

Hepatitis C Antibodies
Hepatitis C
Hepacivirus
contagious disease
Confidence Intervals
Infection
confidence
Health
Nutrition Surveys
health
mental hygiene
Chronic Hepatitis C
Risk-Taking
resident
Population Groups
Disease
Disease Progression
Liver Diseases
Mental Health
local public

Keywords

  • Hepatitis C
  • New York City
  • NYC
  • Prevalence
  • Serosurvey
  • Survey

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Health(social science)

Cite this

Bornschlegel, K., Berger, M., Garg, R. K., Punsalang, A., McKinney, C. M., Gwynn, R. C., & Thorpe, L. (2009). Prevalence of hepatitis C infection in New York City, 2004. Journal of Urban Health, 86(6), 909-917. https://doi.org/10.1007/s11524-009-9396-x

Prevalence of hepatitis C infection in New York City, 2004. / Bornschlegel, Katherine; Berger, Magdalena; Garg, Renu K.; Punsalang, Amado; McKinney, Christy M.; Gwynn, R. Charon; Thorpe, Lorna.

In: Journal of Urban Health, Vol. 86, No. 6, 11.2009, p. 909-917.

Research output: Contribution to journalArticle

Bornschlegel, K, Berger, M, Garg, RK, Punsalang, A, McKinney, CM, Gwynn, RC & Thorpe, L 2009, 'Prevalence of hepatitis C infection in New York City, 2004', Journal of Urban Health, vol. 86, no. 6, pp. 909-917. https://doi.org/10.1007/s11524-009-9396-x
Bornschlegel K, Berger M, Garg RK, Punsalang A, McKinney CM, Gwynn RC et al. Prevalence of hepatitis C infection in New York City, 2004. Journal of Urban Health. 2009 Nov;86(6):909-917. https://doi.org/10.1007/s11524-009-9396-x
Bornschlegel, Katherine ; Berger, Magdalena ; Garg, Renu K. ; Punsalang, Amado ; McKinney, Christy M. ; Gwynn, R. Charon ; Thorpe, Lorna. / Prevalence of hepatitis C infection in New York City, 2004. In: Journal of Urban Health. 2009 ; Vol. 86, No. 6. pp. 909-917.
@article{1ed2ca61e3e54a55b2c8040fef901911,
title = "Prevalence of hepatitis C infection in New York City, 2004",
abstract = "Hepatitis C virus (HCV) is the leading cause of chronic liver disease in the United States. Accurate hepatitis C prevalence estimates are important to guide local public health programs but are usually unavailable to local health jurisdictions. National surveys may not reflect local variation, a particular challenge for urban settings with disproportionately large numbers of residents in high-risk population groups. In 2004, the New York City Department of Health and Mental Hygiene conducted the NYC Health and Nutrition Examination Survey, a population-based household survey of non-institutionalized NYC residents ages 20 and older. Study participants were interviewed and blood specimens were tested for antibody to HCV (anti-HCV); positive participants were re-contacted to ascertain awareness of infection and to provide service referrals. Of 1,786 participants with valid anti-HCV results, 35 were positive for anti-HCV, for a weighted prevalence of 2.2{\%} (95{\%} confidence interval [CI] 1.5{\%} to 3.3{\%}). Anti-HCV prevalence was high among participants with a lifetime history of injection drug use (64.5{\%}, 95{\%} CI 39.2{\%} to 83.7{\%}) or a lifetime history of incarceration as an adult (8.4{\%}, 95{\%} CI 4.3{\%} to 15.7{\%}). There was a strong correlation with age; among participants born between 1945 and 1954, the anti-HCV prevalence was 5.8{\%} (95{\%} CI 3.3{\%} to 10.0{\%}). Of anti-HCV positive participants contacted (51{\%}), 28{\%} (n∈=∈5) first learned of their HCV status from this survey. Continued efforts to prevent new infections in known risk behavior groups are essential, along with expansion of HCV screening and activities to prevent disease progression in people with chronic HCV.",
keywords = "Hepatitis C, New York City, NYC, Prevalence, Serosurvey, Survey",
author = "Katherine Bornschlegel and Magdalena Berger and Garg, {Renu K.} and Amado Punsalang and McKinney, {Christy M.} and Gwynn, {R. Charon} and Lorna Thorpe",
year = "2009",
month = "11",
doi = "10.1007/s11524-009-9396-x",
language = "English (US)",
volume = "86",
pages = "909--917",
journal = "Journal of Urban Health",
issn = "1099-3460",
publisher = "Springer Science and Business Media Deutschland GmbH",
number = "6",

}

TY - JOUR

T1 - Prevalence of hepatitis C infection in New York City, 2004

AU - Bornschlegel, Katherine

AU - Berger, Magdalena

AU - Garg, Renu K.

AU - Punsalang, Amado

AU - McKinney, Christy M.

AU - Gwynn, R. Charon

AU - Thorpe, Lorna

PY - 2009/11

Y1 - 2009/11

N2 - Hepatitis C virus (HCV) is the leading cause of chronic liver disease in the United States. Accurate hepatitis C prevalence estimates are important to guide local public health programs but are usually unavailable to local health jurisdictions. National surveys may not reflect local variation, a particular challenge for urban settings with disproportionately large numbers of residents in high-risk population groups. In 2004, the New York City Department of Health and Mental Hygiene conducted the NYC Health and Nutrition Examination Survey, a population-based household survey of non-institutionalized NYC residents ages 20 and older. Study participants were interviewed and blood specimens were tested for antibody to HCV (anti-HCV); positive participants were re-contacted to ascertain awareness of infection and to provide service referrals. Of 1,786 participants with valid anti-HCV results, 35 were positive for anti-HCV, for a weighted prevalence of 2.2% (95% confidence interval [CI] 1.5% to 3.3%). Anti-HCV prevalence was high among participants with a lifetime history of injection drug use (64.5%, 95% CI 39.2% to 83.7%) or a lifetime history of incarceration as an adult (8.4%, 95% CI 4.3% to 15.7%). There was a strong correlation with age; among participants born between 1945 and 1954, the anti-HCV prevalence was 5.8% (95% CI 3.3% to 10.0%). Of anti-HCV positive participants contacted (51%), 28% (n∈=∈5) first learned of their HCV status from this survey. Continued efforts to prevent new infections in known risk behavior groups are essential, along with expansion of HCV screening and activities to prevent disease progression in people with chronic HCV.

AB - Hepatitis C virus (HCV) is the leading cause of chronic liver disease in the United States. Accurate hepatitis C prevalence estimates are important to guide local public health programs but are usually unavailable to local health jurisdictions. National surveys may not reflect local variation, a particular challenge for urban settings with disproportionately large numbers of residents in high-risk population groups. In 2004, the New York City Department of Health and Mental Hygiene conducted the NYC Health and Nutrition Examination Survey, a population-based household survey of non-institutionalized NYC residents ages 20 and older. Study participants were interviewed and blood specimens were tested for antibody to HCV (anti-HCV); positive participants were re-contacted to ascertain awareness of infection and to provide service referrals. Of 1,786 participants with valid anti-HCV results, 35 were positive for anti-HCV, for a weighted prevalence of 2.2% (95% confidence interval [CI] 1.5% to 3.3%). Anti-HCV prevalence was high among participants with a lifetime history of injection drug use (64.5%, 95% CI 39.2% to 83.7%) or a lifetime history of incarceration as an adult (8.4%, 95% CI 4.3% to 15.7%). There was a strong correlation with age; among participants born between 1945 and 1954, the anti-HCV prevalence was 5.8% (95% CI 3.3% to 10.0%). Of anti-HCV positive participants contacted (51%), 28% (n∈=∈5) first learned of their HCV status from this survey. Continued efforts to prevent new infections in known risk behavior groups are essential, along with expansion of HCV screening and activities to prevent disease progression in people with chronic HCV.

KW - Hepatitis C

KW - New York City

KW - NYC

KW - Prevalence

KW - Serosurvey

KW - Survey

UR - http://www.scopus.com/inward/record.url?scp=73449098125&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73449098125&partnerID=8YFLogxK

U2 - 10.1007/s11524-009-9396-x

DO - 10.1007/s11524-009-9396-x

M3 - Article

VL - 86

SP - 909

EP - 917

JO - Journal of Urban Health

JF - Journal of Urban Health

SN - 1099-3460

IS - 6

ER -